000 | 03430nam a22004935i 4500 | ||
---|---|---|---|
001 | 978-981-19-4711-7 | ||
003 | DE-He213 | ||
005 | 20240729134313.0 | ||
007 | cr nn 008mamaa | ||
008 | 221025s2022 si | s |||| 0|eng d | ||
020 |
_a9789811947117 _9978-981-19-4711-7 |
||
024 | 7 |
_a10.1007/978-981-19-4711-7 _2doi |
|
072 | 7 |
_aMJCL _2bicssc |
|
072 | 7 |
_aMED062000 _2bisacsh |
|
072 | 7 |
_aMJCL _2thema |
|
245 | 1 | 0 | _aPersonalization in Gynecologic Oncology |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2022. |
|
300 |
_aV, 147 p. 16 illus., 10 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aComprehensive Gynecology and Obstetrics, _x2364-219X |
|
505 | 0 | _a1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit. | |
520 | _aThis book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field. . | ||
650 | 0 |
_aOncology. _913364 |
|
650 | 0 | _aGynecology . | |
650 | 0 |
_aCancer _xGenetic aspects. |
|
650 | 0 | _aTumor markers. | |
650 | 1 | 4 |
_aOncology. _913364 |
650 | 2 | 4 | _aGynecology. |
650 | 2 | 4 | _aCancer Genetics and Genomics. |
650 | 2 | 4 | _aTumour Biomarkers. |
700 | 1 |
_aMandai, Masaki. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
830 | 0 |
_aComprehensive Gynecology and Obstetrics, _x2364-219X |
|
856 |
_u#gotoholdings _yAccess resource |
||
912 | _aZDB-2-SME | ||
912 | _aZDB-2-SXM | ||
245 | _h[E-Book] | ||
999 |
_c101358 _d101358 |